Dr. Larry Kaskel speaks with Dr. Jodi Ganz from Olansky Dermatology Associates about the burgeoning field of cosmetic dermatology and its increasing impact on several unexpected aspects of men's and women's health.
New Treatments in Cosmetic Dermatology: Are The [Wrinkle] Lines Blurring?
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Larry Kaskel speaks with Dr. Jodi Ganz from Olansky Dermatology Associates about the burgeoning field of cosmetic dermatology and its increasing impact on several unexpected aspects of men's and women's health.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Medical Industry Feature
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
<p>Digital Therapeutics Clinical Trials: From Design to Data Interpretation </p>
Medical Industry Feature
Engaging Patients and Caregivers About Digital Therapeutics
<p>Engaging Patients and Caregivers About Digital Therapeutics</p>
Medical Industry Feature
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
<p>Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology</p>
CME/CE Broadcast Replay
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
1.00 credits
<p>Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
<p>New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure</p>
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
<p><span data-contrast="auto" xml:lang="EN-US">Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
MinuteCE®
Understanding hypertrophic cardiomyopathy and recent guidelines
0.52 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">Understanding hypertrophic cardiomyopathy and recent guidelines</span></p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?